Rucha Patil Takes The National DHR-ICMR Gold Award for Best Technology
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, reposted from ICMR- National Institute of Immunohaematology on LinkedIn:
”Extremely happy to get this prestigious National DHR-ICMR Gold Award for Best Technology.
Kudos to the entire team.”
Quoting ICMR National Institute of Immunohaematology‘s post:
”We are delighted to share that ICMR- NIIH has received the Gold award for Technology, under the ICMR Intramural category for the technology “Qualitative G6PD Deficiency POC Test”, at the 2nd DHR-ICMR Health Research Excellence Summit 2025, held at ICMR- NIMR, New Delhi on 13-14th November 2025.
Congratulations to the team behind this achievement: Inventors: Dr. Rucha Patil, Dr. Rati Devendra, and Dr. Manisha Madkaikar, Project Team Members: Dr. Tejashree Patole and Puloma Pandey.
A proud moment for all of us at ICMR-NIIH, Mumbai.”
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis